All Stories

  1. Profile of pembrolizumab in the treatment of patients with unresectable or metastatic urothelial carcinoma

    Article • Cancer Management and Research, May 2019, Dove Medical Press

    Dr Masatoshi Eto, Junichi Inokuchi